Artificial intelligence–driven risk prediction of polypharmacy in older adults: current advances, clinical applications, and future perspectives
Due to the ageing of the population, multimorbidity and polypharmacy has significantly increased, causing medication safety to become a global health concern. Traditionally, medication risk assessment methods based on the counts of medications or rule-based criteria are inadequate to perceive the dynamic, individual an...